Arlene B Chapman Selected Research

Chemokine CCL2 (Monocyte Chemoattractant Protein 1)

6/2017

Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arlene B Chapman Research Topics

Disease

68	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2023 - 01/2003
42	Hypertension (High Blood Pressure) 02/2024 - 03/2002
19	Cysts 01/2023 - 09/2003
17	Essential Hypertension 01/2018 - 03/2002
12	Chronic Kidney Failure (Chronic Renal Failure) 10/2022 - 05/2007
11	Disease Progression 07/2021 - 10/2011
8	Chronic Renal Insufficiency 01/2022 - 02/2014
8	Polycystic Kidney Diseases (Polycystic Kidney Disease) 07/2021 - 07/2008
6	Renal Insufficiency (Renal Failure) 01/2023 - 12/2003
5	Hypotension (Low Blood Pressure) 05/2018 - 03/2012
4	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 01/2010
4	Pain (Aches) 01/2020 - 12/2012
4	Kidney Diseases (Kidney Disease) 01/2019 - 02/2017
4	Polycystic liver disease 11/2016 - 01/2003
3	Body Weight (Weight, Body) 12/2022 - 01/2008
3	IGA Glomerulonephritis (IGA Nephropathy) 10/2022 - 11/2012
3	Albuminuria 01/2019 - 10/2011
3	Hyperglycemia 01/2018 - 02/2014
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2015 - 01/2012
2	Hereditary Nephritis (Alport Syndrome) 12/2022 - 01/2021
2	Glomerulonephritis 10/2022 - 11/2014
2	Nocturia 06/2020 - 01/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2014 - 10/2012
2	Stroke (Strokes) 10/2012 - 01/2011
2	Myocardial Infarction 10/2012 - 01/2011
1	Nephrolithiasis 01/2022
1	Hypokalemia 01/2021
1	Hyperuricemia 01/2021
1	Chemical and Drug Induced Liver Injury 12/2020
1	Constipation 01/2020
1	Diarrhea 01/2020

Drug/Important Bio-Agent (IBA)

27	Antihypertensive Agents (Antihypertensives)IBA 02/2024 - 03/2002
24	Tolvaptan FDA Link 08/2021 - 05/2011
19	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 12/2022 - 03/2002
18	Biomarkers (Surrogate Marker)IBA 02/2024 - 12/2003
18	CreatinineIBA 12/2022 - 09/2003
15	TEMPOIBA 08/2021 - 05/2011
10	Atenolol (Tenormin)FDA LinkGeneric 10/2016 - 01/2010
8	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 02/2024 - 11/2002
8	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 07/2021 - 05/2007
7	AlbuminsIBA 12/2022 - 09/2003
7	ReninIBA 11/2019 - 03/2002
7	Vasopressins (Vasopressin)IBA 01/2019 - 05/2011
6	Iothalamic Acid (Iotalamic Acid)FDA Link 12/2018 - 09/2003
5	Proteins (Proteins, Gene)FDA Link 04/2020 - 01/2007
5	trandolapril (Mavik)FDA LinkGeneric 01/2018 - 01/2011
5	Verapamil (Calan)FDA LinkGeneric 01/2018 - 01/2011
4	SodiumIBA 07/2021 - 03/2002
4	AngiotensinsIBA 05/2018 - 03/2012
4	AldosteroneIBA 06/2015 - 03/2002
4	Angiotensin Receptor AntagonistsIBA 01/2015 - 01/2008
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2015 - 10/2011
3	ThiazidesIBA 02/2024 - 01/2018
3	Chlorthalidone (Chlortalidone)FDA LinkGeneric 12/2022 - 12/2017
3	Transaminases (Aminotransferases)IBA 12/2022 - 01/2016
3	Fibroblast Growth Factor-23IBA 04/2021 - 09/2017
3	candesartanIBA 01/2019 - 01/2008
3	DiureticsIBA 01/2018 - 01/2008
3	Diltiazem (Cardizem)FDA LinkGeneric 01/2018 - 08/2013
3	1-dodecylpyridoxal (PLD)IBA 11/2016 - 01/2015
3	Glucose (Dextrose)FDA LinkGeneric 06/2015 - 01/2010
2	ceramide glucosyltransferaseIBA 01/2023 - 10/2022
2	venglustatIBA 01/2023 - 10/2022
2	bardoxolone methylIBA 12/2022 - 01/2021
2	Immunoglobulin A (IgA)IBA 10/2022 - 11/2014
2	Losartan (Cozaar)FDA LinkGeneric 01/2022 - 01/2015
2	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2022 - 12/2017
2	BilirubinIBA 12/2020 - 11/2017
2	Peptides (Polypeptides)IBA 01/2017 - 01/2013
2	Lisinopril (Prinivil)FDA LinkGeneric 12/2014 - 12/2014
2	Telmisartan (Micardis)FDA Link 12/2014 - 12/2014
2	Indicators and Reagents (Reagents)IBA 01/2014 - 07/2013
2	HDL LipoproteinsIBA 01/2013 - 01/2010
2	ElectrolytesIBA 12/2012 - 09/2003
2	HDL CholesterolIBA 01/2012 - 03/2011
2	GadoliniumIBA 02/2010 - 04/2009
2	Uric Acid (Urate)IBA 01/2010 - 01/2007
1	MicroRNAs (MicroRNA)IBA 02/2024
1	Circulating MicroRNAIBA 02/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2024
1	Lysine (L-Lysine)FDA Link 02/2024
1	Natriuretic PeptidesIBA 01/2024
1	Glucosylceramides (Glucocerebrosides)IBA 01/2023
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2022
1	MagnesiumIBA 12/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 10/2022
1	galactosyl-deficient IgA1IBA 10/2022
1	Carvedilol (Coreg)FDA LinkGeneric 01/2022
1	Cystatin CIBA 01/2022
1	Natriuretic AgentsIBA 07/2021
1	PotassiumIBA 01/2021
1	TabletsIBA 06/2020
1	TRPP Cation ChannelsIBA 04/2020
1	2,5- dibromo- 2- (beta- naphthyl)indan- 1,3- dioneIBA 01/2020
1	Dopamine D5 ReceptorsIBA 01/2020

Therapy/Procedure

17	Therapeutics 01/2020 - 12/2003
4	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020 - 01/2015
2	Transplantation 01/2022 - 01/2016
2	Treatment Delay 01/2018 - 01/2017
1	Polypharmacy 01/2022